Om Megashree Pharmaceuticals Limited has begun the process of offering 14,76,000 unit IPO shares at a nominal value of Rs. 100, commencing today, i.e., 27th Falgun, 2081. The closing date for this offering is scheduled for 3rd Chaitra, 2081, with a potential extension until 12th Chaitra, 2081, should it go unsubscribed.
The firm’s issued capital amounts to Rs. 60 Crores, of which 30%, equating to 18,00,000 unit shares worth Rs. 18 Crores, will be made available later to the general public. From this public offering, 10% of the shares, totaling 1,80,000 units, have already been allocated for Nepalese citizens employed abroad. Of the total 18,00,000 units, 90,000 (which is 5% of 18,00,000) have been earmarked for mutual funds, while 54,000 (which is 3% of 18,00,000) units have been reserved for the company’s employees. The remaining 14,76,000 units are available for the general public, with the issuance commencing today.
Prabhu Capital Limited has been designated as the issue manager. Applications can be submitted for a minimum of 10 units and a maximum of 10,000 units.
CARE Ratings Nepal Limited (CRNL) has reaffirmed the ‘CARE-NP BB- (Is)’ rating for Om Megashree Pharmaceuticals Limited (OMPL), suggesting a moderate risk of default for timely financial commitments. Furthermore, CRNL has reaffirmed the ‘CARE-NP BB-‘ rating for OMPL’s long-term bank facilities and the ‘CARE-NP A4’ rating for its short-term bank facilities.
Established on June 12, 2016, Om Megashree Pharmaceuticals Limited is a publicly traded company in Nepal, promoted by a consortium of institutional and individual investors. The company produces pharmaceutical products at its facility in Chitwan and commenced partial operations on February 19, 2024.
